Literature DB >> 16794246

Post-transplant lymphoproliferative disorders.

Ann S LaCasce1.   

Abstract

Post-transplant lymphoproliferative disorder is the most common malignancy, with the exception of skin cancer, after solid organ transplantation in adults. The incidence varies according to the transplanted organ and is often associated with Epstein-Barr virus. Prognosis is variable, due in part to the heterogeneity of the disease, which ranges from reactive plasmacytic hyperplasia to aggressive monoclonal disease.

Entities:  

Mesh:

Year:  2006        PMID: 16794246     DOI: 10.1634/theoncologist.11-6-674

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  34 in total

1.  Small intestinal lymphoma in a post-renal transplant patient: a rare case with late presentation.

Authors:  Ritesh Kumar; Divya Khosla; Rakesh Kapoor; Shreekant Bharti
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 2.  Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.

Authors:  Ajay Major; Manali Kamdar
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

3.  Development of lymphoma from the donor of haploidentical stem cell transplantation: A case report.

Authors:  Linna Xie; Fang Zhou
Journal:  Mol Clin Oncol       Date:  2017-09-19

4.  Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States.

Authors:  Scott C Quinlan; Ruth M Pfeiffer; Lindsay M Morton; Eric A Engels
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

5.  Primary mediastinal large B-cell lymphoma arising from thyroid in a renal recipient with Hashimoto's thyroiditis.

Authors:  Fang Wu; Lu Qu; Dai-Qiang Li; Chun-Hong Hu
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.

Authors:  Petros D Grivas
Journal:  Med Oncol       Date:  2011-09       Impact factor: 3.064

7.  Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders.

Authors:  Jung-Hye Choi; Byeong-Bae Park; Cheolwon Suh; Jong-Ho Won; Won-Sik Lee; Ho-Jin Shin
Journal:  J Korean Med Sci       Date:  2010-03-23       Impact factor: 2.153

Review 8.  Incidence, risk factors and outcomes of de novo malignancies post liver transplantation.

Authors:  Pavan Kedar Mukthinuthalapati; Raghavender Gotur; Marwan Ghabril
Journal:  World J Hepatol       Date:  2016-04-28

9.  A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.

Authors:  Wendell Lake; Julie E Chang; Tabassum Kennedy; Adam Morgan; Shahriar Salamat; Mustafa K Başkaya
Journal:  Neurosurgery       Date:  2013-06       Impact factor: 4.654

10.  Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.

Authors:  Tanner Dalton; Ekaterina Doubrovina; Dmitry Pankov; Raymond Reynolds; Hanna Scholze; Annamalai Selvakumar; Teresa Vizconde; Bhumesh Savalia; Vadim Dyomin; Christoph Weigel; Christopher C Oakes; Alicia Alonso; Olivier Elemento; Heng Pan; Jude M Phillip; Richard J O'Reilly; Benjamin E Gewurz; Ethel Cesarman; Lisa Giulino-Roth
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.